DYRK3 and cancer: Considering that cancer cells are characterized by a high protein synthesis rate, part of the efficacy of the Hsp90 inhibitors may depend on their ability to destabilize DYRK3, thereby promoting SG persistence and perturbing translation restoration after stress.